Jeffrey Testani
Yale University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jeffrey Testani as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:20 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07281014 · Unmitigated Aldosterone Signaling During Standard Clinical MRA DosingYale University · active not recruiting · Heart Failure · principal investigator
- N/ANCT06872645 · Exploring Water-free Sodium StorageYale University · recruiting · Peritoneal Dialysis, Heart Failure · principal investigator
- Ph2NCT06815471 · CRF2 Agonist for the Treatment of Worsening Heart FailureCorteria Pharmaceuticals · suspended · Worsening Heart Failure · study chair
- Ph1NCT06209359 · Mechanisms of Diuretic Resistance in Heart Failure, Aim 3Yale University · recruiting · Heart Failure, Diuretic Resistance · principal investigator
- Ph1NCT05753059 · Mechanisms of Diuretic Resistance in Heart Failure, Aim 2Yale University · recruiting · Heart Failure · principal investigator
- Ph2NCT05726032 · Empagliflozin in Patients With Cirrhosis and AscitesYale University · recruiting · Cirrhosis, Liver Failure · principal investigator
- Ph4NCT05671991 · Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal DiseaseYale University · active not recruiting · End Stage Renal Disease on Dialysis · principal investigator
- Ph1NCT05553938 · Effects of Acute and Chronic Empagliflozin Heart FailureYale University · active not recruiting · Heart Failure · principal investigator
- Ph1NCT05323487 · Mechanisms of Diuretic Resistance in Heart Failure, Aim 1Yale University · recruiting · Heart Failure · principal investigator
- Ph2NCT04438213 · Ertugliflozin in Chronic Heart FailureYale University · recruiting · Heart Failure · principal investigator
- Ph1NCT03093090 · Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: FurosemideYale University · withdrawn · Medication Absorption · principal investigator
- Ph1NCT03027960 · Empagliflozin in Heart Failure: Diuretic and Cardio-Renal EffectsYale University · completed · Heart Failure, Type II; Diabetes · principal investigator
- Ph1NCT02546583 · Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart FailureYale University · completed · Heart Failure · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Exploring water free sodium storageR01DK138155 · NIDDK · YALE UNIVERSITY · fiscal years 2024 to 2026 · $726,880 awarded in 2026Grant number is on one of their registry trials
- Mechanism and Effects of Manipulating Chloride Homeostasis in Heart FailureR01HL139629 · NHLBI · YALE UNIVERSITY · fiscal years 2018 to 2026 · $839,984 awarded in 2026Same name and institution; not confirmed by an ID
- Mechanisms of diuretic resistance in heart failureR01DK130997 · NIDDK · YALE UNIVERSITY · fiscal years 2022 to 2026 · $730,135 awarded in 2026Grant number is on one of their registry trials
- Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-StudyR01HL148354 · NHLBI · YALE UNIVERSITY · fiscal years 2019 to 2022 · $830,750 awarded in 2022Same name and institution; not confirmed by an ID
- Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart FailureR01HL128973 · NHLBI · YALE UNIVERSITY · fiscal years 2015 to 2019 · $751,355 awarded in 2019Grant number is on one of their registry trials
- Urine galectin-3 as a biomarker of cardio-renal phenotype and prognosisR21HL143092 · NHLBI · YALE UNIVERSITY · fiscal years 2018 to 2019 · $125,625 awarded in 2019Same name and institution; not confirmed by an ID
- Cardio-renal phenotype and prognosis in chronic heart failureK23HL114868 · NHLBI · YALE UNIVERSITY · fiscal years 2012 to 2017 · $189,964 awarded in 2017Same name and institution; not confirmed by an ID
- Evaluating predictive methods and product performance in Healthy Adults for Pediatric Patients, Case Study: FurosemideU01FD005969 · FDA · YALE UNIVERSITY · fiscal years 2016 · $157,731 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:20 UTC. The ranking covers the 200 most relevant of 53 PubMed records, and a shared surname and initials can bring in a namesake. All 53 on PubMed
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.N Engl J Med · 20211,491 citationsRCR 97.7
- Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.Circulation · 2010551 citationsRCR 15.0
- Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.Circulation · 2020346 citationsRCR 17.8
- Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.Circulation · 2018304 citationsRCR 13.2
- Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial.Lancet · 2015291 citationsRCR 12.1
- Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure.Circ Heart Fail · 2014269 citationsRCR 9.2
- Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction.Circ Heart Fail · 2011190 citationsRCR 5.1
- Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.J Am Coll Cardiol · 2016186 citationsRCR 6.6
- Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial.BMJ · 2021168 citationsRCR 11.8
- 161 citationsRCR 16.7